Efstathios Divaris, Ioannis Konstantinidis, Paraskevi Karvouni, Eleni Gavriilaki, Sofia Vakalopoulou, Dimitrios G Goulis, Panagiotis Anagnostis
{"title":"血友病 A 型和 B 型患者的骨折风险:系统综述与 Meta 分析。","authors":"Efstathios Divaris, Ioannis Konstantinidis, Paraskevi Karvouni, Eleni Gavriilaki, Sofia Vakalopoulou, Dimitrios G Goulis, Panagiotis Anagnostis","doi":"10.1111/hae.70033","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Haemophilia A and B is a disease consistently associated with reduced bone mineral density, both in adults and children. However, whether haemophilia also increases fracture risk has not yet been proven.</p><p><strong>Aim: </strong>This systematic review and meta-analysis aimed to synthesize and analyse studies evaluating the association between haemophilia and fracture risk.</p><p><strong>Methods: </strong>Comprehensive research was conducted in three electronic databases (PubMed, CENTRAL, and Scopus) up to 30 June 2024. Data were expressed as relative risk (RR) with 95% confidence intervals (CI). The I<sup>2</sup> index was employed to evaluate heterogeneity.</p><p><strong>Results: </strong>Fourteen studies were included in the qualitative and four in the quantitative analysis (participants: 13,221, publication years: 2007-2022). Regarding design, five studies were retrospective cohorts, two were case-control, and seven were cross-sectional. Fracture prevalence in people with haemophilia (PWH) was 5.7%, ranging from 1.4% to 27.7% (data from 14 studies), compared with 0.9% in the control group, ranging from 0% to 5.1% (data from 3 studies). In comparison with healthy men, PWH demonstrated increased fracture risk (RR 4.56, 95% CI 1.28-16.25, p = 0.019, I<sup>2</sup> 90.74%). However, there was insufficient data to categorize fractures according to their location and to compare fracture incidence between patients receiving prophylaxis and those on-demand treatment, as well as according to the type or severity of haemophilia.</p><p><strong>Conclusion: </strong>This is the first meta-analysis showing a more than 4-fold increased fracture risk in PWH compared with the general population.</p>","PeriodicalId":12819,"journal":{"name":"Haemophilia","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fracture Risk in People With Haemophilia A and B: A Systematic Review and Meta-Analysis.\",\"authors\":\"Efstathios Divaris, Ioannis Konstantinidis, Paraskevi Karvouni, Eleni Gavriilaki, Sofia Vakalopoulou, Dimitrios G Goulis, Panagiotis Anagnostis\",\"doi\":\"10.1111/hae.70033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Haemophilia A and B is a disease consistently associated with reduced bone mineral density, both in adults and children. However, whether haemophilia also increases fracture risk has not yet been proven.</p><p><strong>Aim: </strong>This systematic review and meta-analysis aimed to synthesize and analyse studies evaluating the association between haemophilia and fracture risk.</p><p><strong>Methods: </strong>Comprehensive research was conducted in three electronic databases (PubMed, CENTRAL, and Scopus) up to 30 June 2024. Data were expressed as relative risk (RR) with 95% confidence intervals (CI). The I<sup>2</sup> index was employed to evaluate heterogeneity.</p><p><strong>Results: </strong>Fourteen studies were included in the qualitative and four in the quantitative analysis (participants: 13,221, publication years: 2007-2022). Regarding design, five studies were retrospective cohorts, two were case-control, and seven were cross-sectional. Fracture prevalence in people with haemophilia (PWH) was 5.7%, ranging from 1.4% to 27.7% (data from 14 studies), compared with 0.9% in the control group, ranging from 0% to 5.1% (data from 3 studies). In comparison with healthy men, PWH demonstrated increased fracture risk (RR 4.56, 95% CI 1.28-16.25, p = 0.019, I<sup>2</sup> 90.74%). However, there was insufficient data to categorize fractures according to their location and to compare fracture incidence between patients receiving prophylaxis and those on-demand treatment, as well as according to the type or severity of haemophilia.</p><p><strong>Conclusion: </strong>This is the first meta-analysis showing a more than 4-fold increased fracture risk in PWH compared with the general population.</p>\",\"PeriodicalId\":12819,\"journal\":{\"name\":\"Haemophilia\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-03-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Haemophilia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/hae.70033\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haemophilia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/hae.70033","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
血友病A和B是一种始终与骨密度降低相关的疾病,在成人和儿童中都是如此。然而,血友病是否也会增加骨折风险尚未得到证实。目的:本系统综述和荟萃分析旨在综合和分析评估血友病与骨折风险之间关系的研究。方法:截止到2024年6月30日,在PubMed、CENTRAL和Scopus三个电子数据库中进行综合研究。数据以相对危险度(RR)表示,95%置信区间(CI)。采用I2指数评价异质性。结果:定性分析纳入14项研究,定量分析纳入4项研究(参与者:13221人,发表年份:2007-2022)。在设计方面,5项研究为回顾性队列,2项为病例对照,7项为横断面。血友病(PWH)患者骨折患病率为5.7%,范围从1.4%到27.7%(来自14项研究的数据),而对照组为0.9%,范围从0%到5.1%(来自3项研究的数据)。与健康男性相比,PWH患者骨折风险增加(RR 4.56, 95% CI 1.28-16.25, p = 0.019, I2 90.74%)。然而,没有足够的数据来根据骨折的位置进行分类,比较接受预防治疗和按需治疗的患者之间的骨折发生率,以及根据血友病的类型或严重程度。结论:这是首个显示PWH患者骨折风险比普通人群增加4倍以上的荟萃分析。
Fracture Risk in People With Haemophilia A and B: A Systematic Review and Meta-Analysis.
Introduction: Haemophilia A and B is a disease consistently associated with reduced bone mineral density, both in adults and children. However, whether haemophilia also increases fracture risk has not yet been proven.
Aim: This systematic review and meta-analysis aimed to synthesize and analyse studies evaluating the association between haemophilia and fracture risk.
Methods: Comprehensive research was conducted in three electronic databases (PubMed, CENTRAL, and Scopus) up to 30 June 2024. Data were expressed as relative risk (RR) with 95% confidence intervals (CI). The I2 index was employed to evaluate heterogeneity.
Results: Fourteen studies were included in the qualitative and four in the quantitative analysis (participants: 13,221, publication years: 2007-2022). Regarding design, five studies were retrospective cohorts, two were case-control, and seven were cross-sectional. Fracture prevalence in people with haemophilia (PWH) was 5.7%, ranging from 1.4% to 27.7% (data from 14 studies), compared with 0.9% in the control group, ranging from 0% to 5.1% (data from 3 studies). In comparison with healthy men, PWH demonstrated increased fracture risk (RR 4.56, 95% CI 1.28-16.25, p = 0.019, I2 90.74%). However, there was insufficient data to categorize fractures according to their location and to compare fracture incidence between patients receiving prophylaxis and those on-demand treatment, as well as according to the type or severity of haemophilia.
Conclusion: This is the first meta-analysis showing a more than 4-fold increased fracture risk in PWH compared with the general population.
期刊介绍:
Haemophilia is an international journal dedicated to the exchange of information regarding the comprehensive care of haemophilia. The Journal contains review articles, original scientific papers and case reports related to haemophilia care, with frequent supplements. Subjects covered include:
clotting factor deficiencies, both inherited and acquired: haemophilia A, B, von Willebrand''s disease, deficiencies of factor V, VII, X and XI
replacement therapy for clotting factor deficiencies
component therapy in the developing world
transfusion transmitted disease
haemophilia care and paediatrics, orthopaedics, gynaecology and obstetrics
nursing
laboratory diagnosis
carrier detection
psycho-social concerns
economic issues
audit
inherited platelet disorders.